Ardent Health Partners, Inc. (ARDT) Stock Forecast & Price Target
Ardent Health Partners, Inc. · NYSE
$10.77-0.14 (-1.28%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering Ardent Health Partners, Inc, 7 rate it Buy or better, 4 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $10.00 to $19.00, a moderate spread. The average target of $13.59 sits 26% above the current $10.77. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 4% this year and 5% next, consensus EPS building from about $0.34 next quarter toward $1.25 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Moderate Buy
Strong Buy00%
Buy758%
Hold433%
Sell18%
Strong Sell00%
Based on 12 analysts giving stock ratings to Ardent Health Partners, Inc.
As of Sep, 7 of 12 firms rate ARDT a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
ARDT EPS & revenue forecast
EPS · NEXT QUARTER
$0.34
Range $0.28 – $0.43 · 4 analysts · -5% YoY
Next period, 4 analysts expect Ardent Health Partners, Inc. to earn $0.34 a share (range $0.28 – $0.43), versus $0.36 a year earlier. Full-year consensus is $1.09, growing to $1.25 the year after.
REVENUE · NEXT QUARTER
$1.6B
Range $1.6B – $1.7B · 4 analysts · +4% YoY
Revenue is expected to reach $1.6B (range $1.6B – $1.7B), +4.0% year-over-year. Full-year consensus is $6.5B, rising to $6.7B next year.
Top analysts covering Ardent Health Partners, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ARDT.
#1
DM
David Macdonald
Truist Securities · Rank #109
Buy
$13.00+20.7% to target
Overall win rate
48%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #149
Buy
$13.00+20.7% to target
Overall win rate
44%
+ Follow
#3
Jason Cassorla
Guggenheim
Buy
$14.00+30.0% to target
Coverage
—
+ Follow
#4
Craig Hettenbach
Morgan Stanley
Hold
$12.00+11.4% to target
Coverage
—
+ Follow
#5
Kevin Fischbeck
B of A Securities
Sell
$9.00-16.4% to target
Coverage
—
+ Follow
ARDT stock forecast FAQ
What is ARDT's average 12-month price target?+
The 11 analysts with a live target average $13.59 for Ardent Health Partners, Inc. over the next 12 months, ranging from a $19.00 high to a $10.00 low.
Is ARDT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 12 analyst ratings, 7 are Buy or Strong Buy, 4 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for ARDT?+
The Street-high target is $19.00 (Goldman Sachs), and the Street-low is $10.00 (B of A Securities). The average of all 11 active targets is $13.59.
How many Wall Street analysts cover ARDT?+
12 analysts have an active rating on Ardent Health Partners, Inc., and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering ARDT?+
Among analysts who currently cover ARDT, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #109). Their current call is Buy with a $13.00 target.
What is Ardent Health Partners, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.34 per share (range $0.28 – $0.43) across 4 analysts. Full-year EPS is projected at $1.09, rising to $1.25 the following year.
How much revenue is Ardent Health Partners, Inc. expected to report next quarter?+
Consensus revenue is $1.6B (range $1.6B – $1.7B). Full-year revenue is projected at $6.5B, growing to $6.7B next year.
Have analysts been upgrading or downgrading ARDT lately?+
As of Sep, 7 of 12 firms rate ARDT a Buy (4 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ARDT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
